Gynaecological Cancer

Looking for a clinical protocol in a hurry?

Gynaecology SACT regimens:

Whilst every effort is made to ensure the accuracy of the information in a given regimen it cannot be guaranteed that the regimen is fully up to date, because of the dynamic nature of cancer treatment. Check the regimen details for the specific indication the regimen may be used / funded in. See our disclaimer.

Thames Valley have agreed that an H2 antagonist is no longer required as premedication before paclitaxel doses.
Therefore H2 antagonist premedication may be omitted from paclitaxel regimens.

Paclitaxel may be administered via a DEHP free line instead of the polyethylene lined giving set specified in the regimens.

Cervix

Endometrial

Ovarian / Uterine

Vulva / Vagina

Gestational trophoblastic disease

Non-seminomatous germ cell tumours

Cisplatin hydration

SACT regimens written by S Coutts

For further information please contact us using our contact us page.

Last Updated on 24/12/2025 by admin